Elan seeks $800m HY bond to fend off hostile takeover
Irish drug company Elan plans to sell an $800m high yield bond as part of its plan to fend off a hostile takeover.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
